In Informal Guidance given by SEBI regarding SEBI (Delisting of Securities) Guidelines, 2003 and SEBI (Delisting of Equity Shares) Regulations, 2009 to Enam Securities Pvt Limited for M/s Arch Pharmalabs Ltd, states that Regulation 31 of the Delisting Regulations provides that any act done or omitted to be done or a right privilege, obligation or liability accrued under the Delisting Guidelines prior to commencement of the Delisting Regulations, shall be governed by the Delisting Guidelines. Further, any rights or privilege available to the company under Delisting Guidelines (Since rescinded) is saved and shall be governed by the Delisting Regulations.
Show Cause Notice for Compulsory Delisting
30 Mar 2010
Delhi Stock Exchange Limited in pursuance of the Regulation 22 of Chapter V of SEBI (Delisting of Equity Shares) Regulations, 2009 is processing for Compulsory Delisting of the securities of the 150 companies which are suspended thereat and given an opportunity to the companies to make a repersentation before Mr. A K Shandilya, Head (Listing) showing cause why their securities should not be compulsorily delisted within 15 days from the date of publication of this Notice.
Applicability of Delisting Regulations
14 Sep 2009
The Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 (Delisting Regulations) were notified by SEBI on June 10, 2009 and since SEBI has been receiving queries from various market participants, listed companies etc regarding the ‘transitional provisions’ contained in regulation 31 of the Delisting Regulations. In this regard few clarifications has been given.